Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition
Authors:
Open Access
- 23 August 2024
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 760, 110135
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Artepillin C overcomes apalutamide resistance through blocking androgen signaling in prostate cancer cellsArchives of Biochemistry and Biophysics, 2023
- Apalutamide and autophagy inhibition in a xenograft mouse model of human prostate cancerJournal of Cancer Research and Clinical Oncology, 2022
- Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquineMedical Oncology, 2021
- Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancerWorld Journal of Urology, 2018
- Small fluorescent molecules for monitoring autophagic fluxFEBS Letters, 2018
- Androgen deprivation and androgen receptor competition by bicalutamide induce autophagy of hormone‐resistant prostate cancer cells and confer resistance to apoptosisThe Prostate, 2013
- Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expressionApoptosis, 2008
- Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarizationBreast Cancer Research and Treatment, 2008
- Phospholipase A2 inhibition by alkylbenzoylacrylic acidsBiochemical Pharmacology, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976